DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) — all Canadian products
9 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02491753 | DOVATO | VIIV HEALTHCARE ULC | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; LAMIVUDINE 300 MG | Marketed | |
| 02475774 | JULUCA | VIIV HEALTHCARE ULC | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE) 25 MG | Marketed | |
| 02556782 | PMS-DOLUTEGRAVIR | PHARMASCIENCE INC | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG | Marketed | |
| 02501457 | SANDOZ DOLUTEGRAVIR | SANDOZ CANADA INCORPORATED | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG | Approved | |
| 02511517 | TIVICAY | VIIV HEALTHCARE ULC | Tablet For Suspension | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 5 MG | Marketed | |
| 02414945 | TIVICAY | VIIV HEALTHCARE ULC | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG | Marketed | |
| 02430932 | TRIUMEQ | VIIV HEALTHCARE ULC | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; ABACAVIR (ABACAVIR SULFATE) 600 MG; LAMIVUDINE 300 MG | Marketed | |
| 02461226 | TIVICAY | VIIV HEALTHCARE ULC | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 25 MG | Cancelled Post Market | |
| 02461218 | TIVICAY | VIIV HEALTHCARE ULC | Tablet | Oral | DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 10 MG | Cancelled Post Market |
Browse other molecules: